SJ Medical
The global healthcare sector is witnessing a paradigm shift toward minimally invasive procedures, and atherectomy systems stand at the forefront of this evolution. As a specialized manufacturer and exporter, we recognize that the industry is no longer just about removing plaque; it's about vascular restoration and improving long-term patient outcomes.
Global Market CAGR
PAD Patients Globally
Certified Standards
Export Countries
Modern atherectomy technology has branched into several specialized modalities: Rotational, Orbital, Directional, and Laser. The current industrial trend emphasizes precision-guided debulking. Hospitals worldwide are increasingly moving away from high-pressure balloon angioplasty, which can cause vessel trauma, toward atherectomy systems that offer a "vessel preparation" approach. This preparation is crucial before drug-coated balloon (DCB) application or stenting, especially in heavily calcified lesions.
As an industry leader, Hangzhou SJ Medical Co., Ltd. integrates AI-assisted manufacturing and high-precision engineering to meet these complex clinical needs. The integration of High Conductivity Copper Clad Steel Wire in our systems ensures the electrical integrity and torque control required for high-speed rotational components.
International procurement officers and hospital administrators look for three pillars when sourcing Atherectomy systems: Reliability, Cost-Efficiency, and Regulatory Compliance. Our export model is designed to simplify the supply chain, providing comprehensive documentation (CE, ISO 13485) and local technical support.
Application varies significantly by region. In North America and Europe, the focus is on treating Peripheral Artery Disease (PAD) in aging populations. In emerging markets across Asia and the Middle East, there is a surging demand for cost-effective solutions for Coronary Artery Disease (CAD). Our products are engineered to perform in diverse clinical environments, from high-volume city hospitals to specialized rural surgical centers.
The "Made in China" label in the medical device field has evolved into a symbol of High-Tech Precision and Scalable Quality. At SJ Medical, our advantage lies in our vertically integrated manufacturing process. By controlling everything from the raw materials (like high-conductivity alloys) to the final sterile packaging, we ensure a level of quality control that exceeds international standards while maintaining competitive global pricing.
Hangzhou SJ Medical Co., Ltd. was established in 2015 and is dedicated to the research, development, manufacturing, and commercialization of vascular interventional medical devices. The company focuses on both cardiovascular and peripheral intervention fields, striving to provide safe, reliable, and innovative solutions for healthcare providers worldwide.
SJ Medical operates a modern manufacturing facility with a total area of approximately 5,000 square meters. The factory is built in accordance with GMP standards and features a high-standard cleanroom environment, including a million-class clean workshop with localized hundred-class areas for critical processes.
Our product range integrates interventional access systems, diagnostic catheters, and therapeutic devices. Each product is developed with an emphasis on precision, safety, and clinical performance. They play an important role in the diagnosis and treatment of vascular diseases, helping to improve procedural efficiency while enhancing patient safety and recovery.
We have obtained CE certification, ISO 13485, and CFDA approval. Our products are currently distributed in countries such as Finland, Italy, Spain, France, the Netherlands, India, Indonesia, Turkey, and Egypt. We continue to expand our international footprint to strengthen our global presence.
The company is equipped with advanced production systems, including precision balloon forming equipment and laser welding technologies. From pre-sales consultation to responsive after-sales service, we ensure every customer receives professional and reliable solutions.